Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takashi Inozume

Showing results (11-20 of 89) with videos related to

Pageof 9
Sort By:
European Journal of Dermatology : EJD|November 26, 2024
A case of basal cell carcinosarcoma with a melanocytic componentKeijun Yoshino, Takamitsu Matsuzawa, Takanori Aihara, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2009
IL-17 secreted by tumor reactive T cells induces IL-8 release by human renal cancer cellsTakashi Inozume, Ken-ichi Hanada, Qiong J Wang, et al.
European Journal of Dermatology : EJD|July 17, 2024
Acquired tufted angioma with perinatal progression and complete spontaneous regression post-delivery: a case report and literature review on the expression of sex hormone receptorsAsuka Kawano, Hideaki Miyachi, Masayuki Ota, et al.
Blood|February 9, 2011
Molecular identification of an MHC-independent ligand recognized by a human {alpha}/{beta} T-cell receptorKen-ichi Hanada, Qiong J Wang, Takashi Inozume, et al.
Case Reports in Dermatology|December 3, 2011
A Case of Metastatic Extramammary Paget's Disease Responding to Trastuzumab plus Paclitaxel Combination TherapyFumie Hanawa, Takashi Inozume, Kazutoshi Harada, et al.
Journal of Dermatological Science|January 11, 2011
Novel immunotherapeutic approaches to skin cancer treatments using protein transduction technologyNaotaka Shibagaki, Takashi Okamoto, Hiroshi Mitsui, et al.
The Journal of Investigative Dermatology|January 15, 2016
Melanoma Cells Control Antimelanoma CTL Responses via Interaction between TIGIT and CD155 in the Effector PhaseTakashi Inozume, Tomonori Yaguchi, Junpei Furuta, et al.
The Journal of Dermatology|September 18, 2018
Acquisition of resistance to vemurafenib leads to interleukin-10 production through an aberrant activation of Akt in a melanoma cell lineTakashi Inozume, Toshiyuki Tsunoda, Takashi Morisaki, et al.
The Journal of Dermatology|October 29, 2018
Cytotoxic T-lymphocyte-associated protein 4 expressed by melanoma cells does not affect melanoma-specific cytotoxic T lymphocytes in the effector phaseTakashi Inozume, Ken-Ichi Hanada, Kazuyo Takeda, et al.
The Journal of Dermatology|March 31, 2016
Case of giant cell arteritis as a manifestation of immunoglobulin G4-related diseaseMachiko Takaki, Takashi Inozume, Shinya Sano, et al.
Pageof 9

Showing results (11-20 of 89) with videos related to

Sort By:
Pageof 9
European Journal of Dermatology : EJD|November 26, 2024
A case of basal cell carcinosarcoma with a melanocytic componentKeijun Yoshino, Takamitsu Matsuzawa, Takanori Aihara, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2009
IL-17 secreted by tumor reactive T cells induces IL-8 release by human renal cancer cellsTakashi Inozume, Ken-ichi Hanada, Qiong J Wang, et al.
European Journal of Dermatology : EJD|July 17, 2024
Acquired tufted angioma with perinatal progression and complete spontaneous regression post-delivery: a case report and literature review on the expression of sex hormone receptorsAsuka Kawano, Hideaki Miyachi, Masayuki Ota, et al.
Blood|February 9, 2011
Molecular identification of an MHC-independent ligand recognized by a human {alpha}/{beta} T-cell receptorKen-ichi Hanada, Qiong J Wang, Takashi Inozume, et al.
Case Reports in Dermatology|December 3, 2011
A Case of Metastatic Extramammary Paget's Disease Responding to Trastuzumab plus Paclitaxel Combination TherapyFumie Hanawa, Takashi Inozume, Kazutoshi Harada, et al.
Journal of Dermatological Science|January 11, 2011
Novel immunotherapeutic approaches to skin cancer treatments using protein transduction technologyNaotaka Shibagaki, Takashi Okamoto, Hiroshi Mitsui, et al.
The Journal of Investigative Dermatology|January 15, 2016
Melanoma Cells Control Antimelanoma CTL Responses via Interaction between TIGIT and CD155 in the Effector PhaseTakashi Inozume, Tomonori Yaguchi, Junpei Furuta, et al.
The Journal of Dermatology|September 18, 2018
Acquisition of resistance to vemurafenib leads to interleukin-10 production through an aberrant activation of Akt in a melanoma cell lineTakashi Inozume, Toshiyuki Tsunoda, Takashi Morisaki, et al.
The Journal of Dermatology|October 29, 2018
Cytotoxic T-lymphocyte-associated protein 4 expressed by melanoma cells does not affect melanoma-specific cytotoxic T lymphocytes in the effector phaseTakashi Inozume, Ken-Ichi Hanada, Kazuyo Takeda, et al.
The Journal of Dermatology|March 31, 2016
Case of giant cell arteritis as a manifestation of immunoglobulin G4-related diseaseMachiko Takaki, Takashi Inozume, Shinya Sano, et al.
Pageof 9